- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Medtronic blasts rival's 'threadbare' antitrust lawsuit
The lawsuit filed in February accused Medtronic, which recorded more than $31 billion in revenue in 2022, of selling its "advanced bipolar devices" below cost and bundled with other products.
Bengaluru: Medical technology company Medtronic PLC has asked a US judge in California to dismiss as "threadbare" an antitrust lawsuit from rival device manufacturer Applied Medical Resources Corp accusing it of unlawful discounts and exclusive contracting.
In a filing in Santa Ana federal court, lawyers for Medtronic on Monday night said Applied Medical had failed to show any harm to market competition for a device the two companies make that is used to cut tissue and seal blood vessels during surgery.
Medtronic, the world's largest standalone medical device maker, said Applied Medical mustered "weak" arguments that Medtronic's discount program for hospitals - providing them lower prices for using more than one of the company's products - violated US antitrust provisions.
"Antitrust laws are designed to promote low prices, not high ones, and a competitor may not use these laws to force higher prices to benefit itself," Medtronic's attorneys at law firms Cleary Gottlieb Steen & Hamilton and Greenberg Traurig told US District Judge Cormac Carney.
Attorneys for California-based Applied Medical and a representative for the company did not immediately respond to messages seeking comment.
A Medtronic spokesperson in a statement on Tuesday called Applied Medical's case a "frivolous lawsuit." Medtronic is based in Dublin, Ireland, but has operational headquarters in Minnesota.
The lawsuit filed in February accused Medtronic, which recorded more than $31 billion in revenue in 2022, of selling its "advanced bipolar devices" below cost and bundled with other products.
Hospitals will not purchase rival devices from Applied Medical for fear of losing discounts on other items, the complaint alleged. "Medtronic's conduct has no legitimate business purpose and does not provide any benefits to consumers," the lawsuit said.
Applied Medical's complaint seeks unspecified monetary damages for lost profit and an injunction against alleged efforts to "significantly limit and hinder competition." A hearing in the case is scheduled for July 17.
The case is Applied Medical Resources Corp v. Medtronic Inc, US District Court, Central District of California, No. 8:23-cv-00268-CJC-DFM. For Applied Medical Resources: Stephen Jensen, Stephen Larson and Adam Powell of Knobbe, Martens, Olson & Bear
For Medtronic: Leah Brannon and George Cary of Cleary Gottlieb Steen & Hamilton; and Robert Herrington and Richard Tabura of Greenberg Traurig.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story